GTS5:Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
No edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 75: | Line 75: | ||
|[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]] | |[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]] | ||
|Disease | |Disease | ||
|Fareeda Brohi MBBS (trainee), Eric McGinnis | |||
|2/26/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
| Line 175: | Line 175: | ||
|[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]] | |[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]] | ||
|Disease | |Disease | ||
|Suranjana Banik | |||
|3/5/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
| Line 659: | Line 659: | ||
|[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]] | |[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]] | ||
|Disease | |Disease | ||
|Aviv Oren, MD (trainee); | |||
Karin Miller, MD | |||
|3/25/2024 | |||
| | | | ||
|Pending | |||
| | | | ||
| | |SK | ||
| | | | ||
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO HAEM5. | |Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO HAEM5. | ||
| Line 815: | Line 816: | ||
|[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]] | |[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]] | ||
|Disease | |Disease | ||
|Suranjana Banik | |||
|3/5/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO SKIN5, PEDS5. | |Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO SKIN5, PEDS5. | ||
| Line 993: | Line 994: | ||
|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] | |[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] | ||
|Disease | |Disease | ||
|Parisa Kargaran | |Parisa Kargaran | ||
|1/21/2026 | |1/21/2026 | ||
| | | | ||
| Line 1,004: | Line 1,005: | ||
|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]] | |[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]] | ||
|Disease | |Disease | ||
|Parisa Kargaran | |Parisa Kargaran | ||
|1/21/2026 | |1/21/2026 | ||
| | | | ||